DE69935326D1 - Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung - Google Patents

Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung

Info

Publication number
DE69935326D1
DE69935326D1 DE69935326T DE69935326T DE69935326D1 DE 69935326 D1 DE69935326 D1 DE 69935326D1 DE 69935326 T DE69935326 T DE 69935326T DE 69935326 T DE69935326 T DE 69935326T DE 69935326 D1 DE69935326 D1 DE 69935326D1
Authority
DE
Germany
Prior art keywords
molybden
detoxification
compositions containing
increasing protein
protein anabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935326T
Other languages
English (en)
Other versions
DE69935326T2 (de
Inventor
Brice E Vickery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69935326D1 publication Critical patent/DE69935326D1/de
Publication of DE69935326T2 publication Critical patent/DE69935326T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69935326T 1998-05-28 1999-05-26 Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung Expired - Lifetime DE69935326T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8584598A 1998-05-28 1998-05-28
US85845 1998-05-28
PCT/US1999/011692 WO1999061042A1 (en) 1998-05-28 1999-05-26 Compositions and methods for enhancing protein anabolism and detoxification

Publications (2)

Publication Number Publication Date
DE69935326D1 true DE69935326D1 (de) 2007-04-12
DE69935326T2 DE69935326T2 (de) 2007-10-31

Family

ID=22194335

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935326T Expired - Lifetime DE69935326T2 (de) 1998-05-28 1999-05-26 Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung

Country Status (5)

Country Link
US (1) US6203820B1 (de)
EP (1) EP1083915B1 (de)
AU (1) AU4100199A (de)
DE (1) DE69935326T2 (de)
WO (1) WO1999061042A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2305597C (en) * 1997-11-07 2008-07-29 Conjuchem Inc. Affinity markers for human serum albumin
AU2002213050A1 (en) * 2000-10-06 2002-04-15 F. Timothy Guilford A combination and method of treatment of cancer utilizing a cox-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (hmg-coa) reductase inhibitor
US6605306B1 (en) * 2002-07-01 2003-08-12 Lonny S. Green Food supplement formulation
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20040071681A1 (en) * 2002-10-10 2004-04-15 Lydia Muller Method and composition for reducing cravings for a craved substance
US7547450B2 (en) * 2002-10-24 2009-06-16 Nestec Ltd. Senior feline food
US6913769B2 (en) * 2003-02-18 2005-07-05 Brian Douglas Oslick Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption
EG26569A (en) * 2003-12-23 2014-02-23 احمد قطب عبد الله مجد The element sulfur and its acid formations and derivatives of the enzyme deficiency of the enzyme glutase S transferfrez and epoxide hydrolys for all types of disease associated with this deficiency
US20050256192A1 (en) * 2004-04-30 2005-11-17 Gardiner Paul T Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual
JP2008510494A (ja) * 2004-08-25 2008-04-10 マルチ・フォーミュレーションズ・リミテッド 骨格筋における異化過程の失活及びタンパク質合成のための組成物並びに方法
US20060130675A1 (en) * 2004-11-30 2006-06-22 Crawford David S Transdermal nutritional supplement delivery patch
CN101754755A (zh) * 2007-02-15 2010-06-23 德尔玛-杨有限公司 促进跨粘膜递送的组合物及方法
US20130059913A1 (en) 2010-04-07 2013-03-07 Otsuka Pharmaceutical Factory, Inc. Composition for amelioration of hypoalbuminemia
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CU20200012A7 (es) 2017-08-14 2021-02-04 Axcella Health Inc Composiciones de aminoácidos para el tratamiento de enfermedad hepática
WO2019035953A1 (en) 2017-08-18 2019-02-21 Calwood Nutritionals, Llc COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH, TREATING SKIN, REDUCING WEAR AND DEGRADING FROM AGING AND EXPOSURE AND ENHANCING RECOVERY OF A STRESS SUCH AS EXERCISE AND TRAUMA
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. 筋肉中の脂肪浸潤の治療のための組成物及び方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1263336A (en) * 1968-02-14 1972-02-09 Morton Norwich Products Inc Food composition
US4616039A (en) * 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
US4514421A (en) 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US5071878A (en) 1979-08-30 1991-12-10 Herschler R J Use of methylsulfonylmethane to enhance diet of an animal
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food

Also Published As

Publication number Publication date
US6203820B1 (en) 2001-03-20
EP1083915A4 (de) 2003-09-03
AU4100199A (en) 1999-12-13
EP1083915A1 (de) 2001-03-21
DE69935326T2 (de) 2007-10-31
EP1083915B1 (de) 2007-02-28
WO1999061042A1 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
DE69935326D1 (de) Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung
DE60018907D1 (de) Verfahren und zusammensetzung zur zementierung von bohrlöchern
PT945132E (pt) Composicao de ibuprofeno
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
DE69940256D1 (de) Zusammensetzung zur hautbleichung
ATE444054T1 (de) Schäumende zusammensetzung zur haarreinigung und haarbehandlung
ATE260674T1 (de) Stabilisierte proteinzusammensetzung
DE69809304D1 (de) Zusammensetzung zur Asbestbehandlung
HUP0102850A2 (hu) Eljárások és kompozíciók fehérje funkcióinak meghatározására és módosítóinak azonosítására
ID23757A (id) Komposisi bahan penyempurna
GB9828346D0 (en) Protein and compositions containing it
GB9828354D0 (en) Protein and compositions containing it
GB9828357D0 (en) Protein and compositions containing it
GB9828356D0 (en) Protein and compositions containing it
GB9828355D0 (en) Protein and compositions containing it
GB9828350D0 (en) Protein and compositions containing it
GB9828349D0 (en) Protein and compositions containing it
GB9828345D0 (en) Protein and compositions containing it
PL320387A1 (en) Gas-sensitive ceramic composition
PL320388A1 (en) Gas-sensitive ceramic composition
ID27823A (id) Komposisi untuk penghantar aroma
LV12463A (lv) Brendija ingredientu kompozicija
ID28262A (id) Komposisi herbal untuk propilaksis dan pengobatan aids
GB9900083D0 (en) Protein and compositions containing it
GB9901922D0 (en) Protein and compositions containing it

Legal Events

Date Code Title Description
8364 No opposition during term of opposition